Sector Gamma AS’s Sarepta Therapeutics SRPT Stock Holding History

Sector Gamma AS’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-51,006	Closed	-$3.78M	–	34
2018 Q1	$3.78M	Buy	+51,006	New	+$3.4M	0.68%	27

Other funds holding SRPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Sector Gamma AS's SRPT Position: Q2 2018 in Review

Sector Gamma AS sold out of Sarepta Therapeutics (SRPT) in Q2 2018, closing a stake of 51,006 shares — an estimated $3.78M sold.

Sector Gamma AS first reported a position in SRPT in Q1 2018 and held it in 1 quarter. The position peaked at $3.78M in Q1 2018. 317 funds tracked by Wall St. Rank hold SRPT as of Q2 2018.

Sector Gamma AS reported no remaining Sarepta Therapeutics position as of Q2 2018 after selling out during the quarter.
Sector Gamma AS sold 51,006 Sarepta Therapeutics shares in Q2 2018, an estimated $3.78M.
Sector Gamma AS first reported a position in Sarepta Therapeutics in Q1 2018 and held it in 1 quarter.
Sector Gamma AS's Sarepta Therapeutics position peaked at $3.78M in Q1 2018.
317 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2018.

Based on Sector Gamma AS's 13F filing for Q2 2018, filed 2 Aug 2018.